|
Stringently selective in every detail.
We are generally industry agnostic but do not invest in early stage high technology and biotech companies. While avoiding pure startups with significant technology, we do invest in new enterprises with proven management teams that are seeking to replicate a business in which they have a demonstrated record of success. Our focus is on control investments but we will consider minority positions that come with significant positions of influence. |
